Cargando…
_version_ 1784701022247059456
author Veltroni, Marinella
Pegoraro, Francesco
Scappini, Barbara
Brugnolo, Francesca
Allegro, Elisa
Ermini, Stefano
Tondo, Annalisa
Fotzi, Ilaria
Bambi, Franco
Favre, Claudio
author_facet Veltroni, Marinella
Pegoraro, Francesco
Scappini, Barbara
Brugnolo, Francesca
Allegro, Elisa
Ermini, Stefano
Tondo, Annalisa
Fotzi, Ilaria
Bambi, Franco
Favre, Claudio
author_sort Veltroni, Marinella
collection PubMed
description
format Online
Article
Text
id pubmed-9072268
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-90722682022-05-07 Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP Veltroni, Marinella Pegoraro, Francesco Scappini, Barbara Brugnolo, Francesca Allegro, Elisa Ermini, Stefano Tondo, Annalisa Fotzi, Ilaria Bambi, Franco Favre, Claudio Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2021-12-21 2022 /pmc/articles/PMC9072268/ /pubmed/34932149 http://dx.doi.org/10.1007/s00277-021-04740-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Veltroni, Marinella
Pegoraro, Francesco
Scappini, Barbara
Brugnolo, Francesca
Allegro, Elisa
Ermini, Stefano
Tondo, Annalisa
Fotzi, Ilaria
Bambi, Franco
Favre, Claudio
Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP
title Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP
title_full Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP
title_fullStr Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP
title_full_unstemmed Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP
title_short Off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory aTTP
title_sort off-label caplacizumab as add-on therapy in a 9-year-old boy with refractory attp
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072268/
https://www.ncbi.nlm.nih.gov/pubmed/34932149
http://dx.doi.org/10.1007/s00277-021-04740-4
work_keys_str_mv AT veltronimarinella offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp
AT pegorarofrancesco offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp
AT scappinibarbara offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp
AT brugnolofrancesca offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp
AT allegroelisa offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp
AT erministefano offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp
AT tondoannalisa offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp
AT fotziilaria offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp
AT bambifranco offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp
AT favreclaudio offlabelcaplacizumabasaddontherapyina9yearoldboywithrefractoryattp